ID
39231
Description
Study ID: 111569 Clinical Study ID: 111569 Study Title: A fixed dose, dose-response study for ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01494532 Sponsor: GlaxoSmithKline Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Ropinirole, placebo Study Indication: Parkinson's Disease
Keywords
Versions (7)
- 12/11/19 12/11/19 -
- 12/11/19 12/11/19 -
- 12/11/19 12/11/19 -
- 12/11/19 12/11/19 -
- 12/16/19 12/16/19 -
- 1/9/20 1/9/20 -
- 1/9/20 1/9/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 11, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease
Visit 4; Visit 6: Visit 8 - Pregnancy
- StudyEvent: ODM
Description
Pregnancy
Alias
- UMLS CUI-1
- C0032961
Description
Did a female partner of a male subject become pregnant during the study?
Data type
boolean
Alias
- UMLS CUI [1]
- C0919624
Description
Did the subject become pregnant during the study?
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Similar models
Visit 4; Visit 6: Visit 8 - Pregnancy
- StudyEvent: ODM
No comments